IL159396A0 - Nutritional composition preventing bacterial overgrowth - Google Patents

Nutritional composition preventing bacterial overgrowth

Info

Publication number
IL159396A0
IL159396A0 IL15939602A IL15939602A IL159396A0 IL 159396 A0 IL159396 A0 IL 159396A0 IL 15939602 A IL15939602 A IL 15939602A IL 15939602 A IL15939602 A IL 15939602A IL 159396 A0 IL159396 A0 IL 159396A0
Authority
IL
Israel
Prior art keywords
bacterial overgrowth
nutritional composition
preventing bacterial
composition preventing
mammals
Prior art date
Application number
IL15939602A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8178159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL159396(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of IL159396A0 publication Critical patent/IL159396A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
IL15939602A 2001-07-30 2002-07-25 Nutritional composition preventing bacterial overgrowth IL159396A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01118231A EP1281325A1 (en) 2001-07-30 2001-07-30 Nutritional composition preventing bacterial overgrowth
PCT/EP2002/008336 WO2003011055A1 (en) 2001-07-30 2002-07-25 Nutritional composition preventing bacterial overgrowth

Publications (1)

Publication Number Publication Date
IL159396A0 true IL159396A0 (en) 2004-06-01

Family

ID=8178159

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15939602A IL159396A0 (en) 2001-07-30 2002-07-25 Nutritional composition preventing bacterial overgrowth
IL159396A IL159396A (en) 2001-07-30 2003-12-16 Nutritional composition for preventing bacterial overgrowth

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159396A IL159396A (en) 2001-07-30 2003-12-16 Nutritional composition for preventing bacterial overgrowth

Country Status (17)

Country Link
US (1) US7666830B2 (es)
EP (2) EP1281325A1 (es)
JP (1) JP4383165B2 (es)
KR (1) KR20040019092A (es)
CN (1) CN100341428C (es)
AT (1) ATE354293T1 (es)
BR (2) BRPI0211485B1 (es)
CA (1) CA2451866C (es)
DE (1) DE60218318T2 (es)
ES (1) ES2281539T3 (es)
IL (2) IL159396A0 (es)
MX (1) MXPA04000869A (es)
NO (1) NO20040361L (es)
PL (1) PL366985A1 (es)
RU (1) RU2004105949A (es)
WO (1) WO2003011055A1 (es)
ZA (1) ZA200401607B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538704A (ja) * 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹誘導組成物
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
CA2532473C (en) * 2003-06-23 2013-08-06 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
US10251899B2 (en) 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
JP2013529475A (ja) 2010-06-28 2013-07-22 ネステク ソシエテ アノニム 低カロリー高タンパク質の栄養組成物及び該栄養組成物を用いる方法
IN2014DN03449A (es) * 2011-11-30 2015-06-05 Meiji Co Ltd
KR101505977B1 (ko) * 2014-08-14 2015-03-25 주식회사 정식품 발효성 당류가 저감된 설사 예방 또는 개선용 식이 조성물
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
WO2017117102A1 (en) * 2015-12-28 2017-07-06 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and uses thereof
CN105943463B (zh) * 2016-06-23 2019-03-15 金日制药（中国）有限公司 一种温和的婴童洗发沐浴泡泡
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
JPWO2023106078A1 (es) * 2021-12-10 2023-06-15

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406394A1 (fr) * 1977-10-19 1979-05-18 Bongrain Procede de preparation d'un lactoserum hydrolyse concentre
EP0321603A1 (fr) * 1987-12-23 1989-06-28 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
US5230902A (en) * 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
DE4037497A1 (de) * 1990-11-26 1992-06-11 Juchem Gmbh Futter-trockenmischung
CA2150571C (en) * 1992-11-30 1998-09-29 Seiichi Shimamura Low-phosphorus whey protein, manufacturing method thereof, low-phosphorus purified whey hydrolysate and manufacturing method thereof
NZ248603A (en) * 1993-05-28 1994-12-22 Abbott Lab Nutritional product for enteral nutritional support of hiv victims comprising proteins and fat
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
EP1024709B1 (en) * 1997-09-16 2006-06-14 Societe Des Produits Nestle S.A. Use of an organ-specific nutritional composition
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition

Also Published As

Publication number Publication date
MXPA04000869A (es) 2004-05-21
IL159396A (en) 2006-09-05
KR20040019092A (ko) 2004-03-04
ES2281539T3 (es) 2007-10-01
US7666830B2 (en) 2010-02-23
BR0211485A (pt) 2004-08-17
PL366985A1 (en) 2005-02-07
BRPI0211485B1 (pt) 2018-09-11
CA2451866A1 (en) 2003-02-13
CN1536967A (zh) 2004-10-13
EP1281325A1 (en) 2003-02-05
RU2004105949A (ru) 2005-07-10
JP2004536143A (ja) 2004-12-02
ATE354293T1 (de) 2007-03-15
WO2003011055A1 (en) 2003-02-13
DE60218318D1 (de) 2007-04-05
ZA200401607B (en) 2005-03-10
EP1414316A1 (en) 2004-05-06
US20040248768A1 (en) 2004-12-09
EP1414316B1 (en) 2007-02-21
DE60218318T2 (de) 2007-11-15
CN100341428C (zh) 2007-10-10
NO20040361L (no) 2004-01-27
CA2451866C (en) 2011-07-05
JP4383165B2 (ja) 2009-12-16

Similar Documents

Publication Publication Date Title
IL159396A0 (en) Nutritional composition preventing bacterial overgrowth
DE60044443D1 (de) Aktivmatrixsubstrat, Verfahren zur Herstellung, und dieses enthaltender Bildsensor
WO2003077828A3 (en) Novel florfenicol-type antibiotics
CA2395266A1 (en) Use of acid-stable subtilisin proteases in animal feed
EP1289252A3 (en) Scanner-initiated network-based image input scanning
DE60239508D1 (de) Bildverarbeitungsverfahren zur Regelung der Helligkeit von numerischen Bildern
AU2002364750A1 (en) Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans
ATE481981T1 (de) Behandlung von infektionen des verdauungstrakts mit enzymen
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
CA2378503A1 (en) Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation
GB0301945D0 (en) Dynamic bilevel thresholding of digital images
WO2002074812A3 (en) Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases
PL374524A1 (en) Composition based on triethyl citrate for the treatment of bacterial infections of the skin
DE60138076D1 (de) Bildsignalverbesserung
WO2001027247A3 (en) Lactose hydrolysis
EP1947109A3 (en) Biologically active peptides
AU2002303957A1 (en) Method of treating alzheimer's disease with se-containing peptide
EP1167532A3 (en) Edible transgenic plants expressing mammalian proteins
RU2001135344A (ru) Штамм бактерий Lactobacillus rhamnosus 12L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
DE69802223D1 (de) Verstärkungsverfahren zur Herstellung von Farbbildern
AU2002356730A1 (en) Fermentation process for the preparation of l-amino acids using coryneform bacteria
AU2002342824A1 (en) Process for the preparation of l-amino acids using coryneform bacteria
AU2002358146A1 (en) Transmission and watermarking of video and images
WO2003035858A3 (en) Bacterial polypeptides involved in nucleic acid processing
TW474459U (en) Active pixel sensor with reset transistor separated from voltage source of the other circuit

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed